drugset / Trial / NCT06939582

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

NCT06939582

Phase 1/2 Recruiting 158 enrolled Xingchen Peng
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the safety, tolerance and efficacy of hydroxychloroquine sulfate tablets the prevention and treatment of oral mucositis and dysgeusia in patients undergoing radiotherapy

Timeline

Start
2024-12-22
Primary completion
2025-06-01
Completion
2025-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 200 mg

Indications